Ascletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination
-Initiated global Phase III program for oral small molecule GLP-1, ASC30, which will enroll approximately 4,600 participants with obesity or overweight across two pivotal trials in the U.S., Europe, and Canada. -Positive preclinical data in...
Singapore Immigration Consultancy Unveils Redesigned Website With Free PR Readiness Consultation for Over 200,000 Work Pass Holders in Singapore
The new platform connects EP and S Pass holders directly with SIC's consultants for personalised eligibility assessments, documentation guidance, and appointment booking across three offices in Singapore. SINGAPORE, July 23, 2026 /PRNewswire/ --...